SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities

Molecular Cancer Therapeutics
Antoine AlamFrançoise Bono

Abstract

SAR131675 is a potent and selective VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells with IC(50) values of 20 and 45 nmol/L, respectively. SAR131675 dose dependently inhibited the proliferation of primary human lymphatic cells, induced by the VEGFR-3 ligands VEGFC and VEGFD, with an IC(50) of about 20 nmol/L. SAR131675 was found to be highly selective for VEGFR-3 versus 107 receptors, enzymes, ion channels, and 65 kinases. However, it was moderately active on VEGFR-2 with a VEGFR-3/VEGFR-2 ratio of about 10. SAR131675 had no antiproliferative activity on a panel of 30 tumors and primary cells, further showing its high specificity and indicating that SAR131675 is not a cytotoxic or cytostatic agent. SAR131675 was very well tolerated in mice and showed a potent antitumoral effect in several orthotopic and syngenic models, including mammary 4T1 carcinoma and RIP1.Tag2 tumors. Interestingly, it significantly reduced lymph node invasion and lung metastasis, showing its antilymphangiogenic activity in vivo. Moreover, treatment of mice before resection of 4T1 primary tumors was sufficient to prevent metastasis. Tumor-associated macrophages (TAM) play an important role in tum...Continue Reading

References

Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G AchenS A Stacker
Sep 6, 2002·The American Journal of Pathology·Sebastian F SchoppmannDontscho Kerjaschki
Jan 8, 2004·EMBO Reports·Elke A OberDidier Y R Stainier
Aug 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Lynn K ChangArja Kaipainen
Oct 12, 2004·Biochemical and Biophysical Research Communications·Antoine AlamJean-Marc Herbert
Jan 6, 2005·Journal of the National Cancer Institute·Bronislaw PytowskiMelody A Swartz
Sep 3, 2005·The Journal of Clinical Investigation·Dontscho Kerjaschki
Sep 3, 2005·The Journal of Clinical Investigation·Kazuichi MaruyamaJ Wayne Streilein
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zoltan GombosGeza Acs
Mar 2, 2006·International Journal of Clinical Oncology·Atsuo ShidaKatsuhiko Yanaga
Apr 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·L D CovassinN D Lawson
Aug 1, 2006·The American Journal of Pathology·Terhi KarpanenKari Alitalo
May 24, 2007·British Journal of Cancer·T Kamba, D M McDonald
Jun 4, 2008·Annals of the New York Academy of Sciences·Marc G Achen, Steven A Stacker
Jul 5, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tom DonnemRoy M Bremnes
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michiyo KodamaKazuaki Chayama
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·Jonathan P Sleeman, Wilko Thiele
Feb 25, 2010·Cell·Tuomas Tammela, Kari Alitalo
Mar 13, 2010·The EMBO Journal·Ingrid NilssonLena Claesson-Welsh
Apr 24, 2010·Cancer Metastasis Reviews·Graziella SolinasPaola Allavena
Mar 2, 2011·PloS One·Alan YanBabak J Mehrara
Mar 30, 2011·Circulation·Camilla NorrménKari Alitalo

❮ Previous
Next ❯

Citations

Apr 13, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Alexandros GarouniatisAthanasios G Papavassiliou
Mar 5, 2014·The Journal of Clinical Investigation·Wei ZhengKari Alitalo
Aug 12, 2014·The Journal of Clinical Investigation·Silvia D'AlessioSilvio Danese
Nov 29, 2015·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Bruce A CorlissWalter Lee Murfee
May 28, 2014·Neoplasia : an International Journal for Oncology Research·Jaeyoung J LimRonald J Buckanovich
Dec 27, 2015·Advanced Drug Delivery Reviews·Lothar C Dieterich, Michael Detmar
Apr 10, 2019·Marine Drugs·Huai-Ching TaiShih-Wei Wang
Oct 20, 2020·Frontiers in Physiology·Laura Gutierrez-Miranda, Karina Yaniv
Jun 27, 2019·Cancer Research·Carlotta TacconiSilvia D'Alessio
Apr 10, 2021·Stem Cell Research·Rita MattaAnjelica L Gonzalez
Apr 8, 2020·ACS Pharmacology & Translational Science·Lauren F Sestito, Susan N Thomas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.